Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Clodantoin is a synthetic small molecule antifungal agent belonging to the imidazolidine-dione (hydantoin) class. It is primarily used as a topical medication for the treatment of fungal infections such as those caused by *Candida albicans*. Its mechanism of action involves disruption of fungal cell membrane integrity and function. Clodantoin has been studied up to phase II clinical trials for its antifungal activity[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on clodantoin.